ArticleJournal of drug delivery2016
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.
Article in Journal of drug delivery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 50 citations in OpenAlex.
- Liquid Metal Materials for Tumor Diagnosis and Treatment.Advanced healthcare materials · 2026Review
- Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery Systems.Pharmaceutics · 2025Article
- β-1,3 Glucan Microparticles & Nanoparticles: Fabrication Methods & Applications in Immunomodulation & Targeted Drug Delivery.Advanced healthcare materials · 2025Review
- Unraveling the complex roles of macrophages in obese adipose tissue: an overview.Frontiers of medicine · 2024Review
- Understanding yeast shells: structure, properties and applications.ADMET & DMPK · 2024Review
- One Step Purification-Vaccine Delivery System.Pharmaceutics · 2023Article
- Yeast Particles for Encapsulation of Terpenes and Essential Oils.Molecules (Basel, Switzerland) · 2023Review
- Novel albendazole-glucan particles for enhancing intestinal absorption and improving hepatic targeting.Annals of translational medicine · 2022Article
- Yeast Particles Hyper-Loaded with Terpenes for Biocide Applications.Molecules (Basel, Switzerland) · 2022Article
- Masks for COVID-19.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Review
- Metal-Based Nanomaterials: Work as Drugs and Carriers against Viral Infections.Nanomaterials (Basel, Switzerland) · 2021Review
- Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections.Biological trace element research · 2021Review
- Yeast Particle Encapsulation of Scaffolded Terpene Compounds for Controlled Terpene Release.Foods (Basel, Switzerland) · 2021Article
- Mini/Micro/Nano Scale Liquid Metal Motors.Micromachines · 2021Review
- Nanotechnology for virus treatment.Nano today · 2021Review
- Anthelmintic Activity of Yeast Particle-Encapsulated Terpenes.Molecules (Basel, Switzerland) · 2020Article
- Progress and Perspective of Antiviral Protective Material.Advanced fiber materials · 2020Review
- Article
- Targeted SHP-1 Silencing Modulates the Macrophage Phenotype, Leading to Metabolic Improvement in Dietary Obese Mice.Molecular therapy. Nucleic acids · 2019Article
- Nanostructured Oxides Containing Ga: Materials with Unique Properties for Aqueous-Based Applications.ACS omega · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Glucan particles (GPs) are hollow, porous 3-5
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.